| Vincent Alan Chavanon, MD | |
|
125 W Copeland Dr, Orlando, FL 32806-2101 | |
| (321) 841-7090 | |
| (321) 843-2267 |
| Full Name | Vincent Alan Chavanon |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 11 Years |
| Location | 125 W Copeland Dr, Orlando, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548502396 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Orlando Health | Orlando, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orlando Health Medical Group Inc | 9537059084 | 1417 |
News Archive
In the fight against "superbugs," scientists have discovered a class of agents that can make some of the most notorious strains vulnerable to the same antibiotics that they once handily shrugged off. The report on the promising agents called metallopolymers appears in the Journal of the American Chemical Society.
Building on their 2005 discovery of an enzyme that is a natural tumor suppressor, researchers at the University of California, San Diego (UCSD) School of Medicine have now identified two variants of that enzyme which could provide new targets for therapies to treat diabetes, heart and neurological disease.
Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array technology, today announced results of a pilot study to measure biomarkers of inflammation from patients with Crohn's disease.
Researchers led by Deborah Gustafson, PhD, MS, professor of neurology at SUNY Downstate Medical Center, have shown that women with a gene variant (APOEe4 allele) associated with Alzheimer's disease experience a steeper decline in body mass index (BMI) after age 70 than those women without the version of the gene, whether they go on to develop dementia or not.
› Verified 6 days ago
| Entity Name | Orlando Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669429577 PECOS PAC ID: 9537059084 Enrollment ID: O20040318000044 |
News Archive
In the fight against "superbugs," scientists have discovered a class of agents that can make some of the most notorious strains vulnerable to the same antibiotics that they once handily shrugged off. The report on the promising agents called metallopolymers appears in the Journal of the American Chemical Society.
Building on their 2005 discovery of an enzyme that is a natural tumor suppressor, researchers at the University of California, San Diego (UCSD) School of Medicine have now identified two variants of that enzyme which could provide new targets for therapies to treat diabetes, heart and neurological disease.
Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array technology, today announced results of a pilot study to measure biomarkers of inflammation from patients with Crohn's disease.
Researchers led by Deborah Gustafson, PhD, MS, professor of neurology at SUNY Downstate Medical Center, have shown that women with a gene variant (APOEe4 allele) associated with Alzheimer's disease experience a steeper decline in body mass index (BMI) after age 70 than those women without the version of the gene, whether they go on to develop dementia or not.
› Verified 6 days ago
| Entity Name | Gardens Plastic Surgery |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235248162 PECOS PAC ID: 7618995259 Enrollment ID: O20051102000969 |
News Archive
In the fight against "superbugs," scientists have discovered a class of agents that can make some of the most notorious strains vulnerable to the same antibiotics that they once handily shrugged off. The report on the promising agents called metallopolymers appears in the Journal of the American Chemical Society.
Building on their 2005 discovery of an enzyme that is a natural tumor suppressor, researchers at the University of California, San Diego (UCSD) School of Medicine have now identified two variants of that enzyme which could provide new targets for therapies to treat diabetes, heart and neurological disease.
Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array technology, today announced results of a pilot study to measure biomarkers of inflammation from patients with Crohn's disease.
Researchers led by Deborah Gustafson, PhD, MS, professor of neurology at SUNY Downstate Medical Center, have shown that women with a gene variant (APOEe4 allele) associated with Alzheimer's disease experience a steeper decline in body mass index (BMI) after age 70 than those women without the version of the gene, whether they go on to develop dementia or not.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vincent Alan Chavanon, MD 125 W Copeland Dr, Orlando, FL 32806-2101 Ph: (321) 841-7090 | Vincent Alan Chavanon, MD 125 W Copeland Dr, Orlando, FL 32806-2101 Ph: (321) 841-7090 |
News Archive
In the fight against "superbugs," scientists have discovered a class of agents that can make some of the most notorious strains vulnerable to the same antibiotics that they once handily shrugged off. The report on the promising agents called metallopolymers appears in the Journal of the American Chemical Society.
Building on their 2005 discovery of an enzyme that is a natural tumor suppressor, researchers at the University of California, San Diego (UCSD) School of Medicine have now identified two variants of that enzyme which could provide new targets for therapies to treat diabetes, heart and neurological disease.
Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array technology, today announced results of a pilot study to measure biomarkers of inflammation from patients with Crohn's disease.
Researchers led by Deborah Gustafson, PhD, MS, professor of neurology at SUNY Downstate Medical Center, have shown that women with a gene variant (APOEe4 allele) associated with Alzheimer's disease experience a steeper decline in body mass index (BMI) after age 70 than those women without the version of the gene, whether they go on to develop dementia or not.
› Verified 6 days ago
Dr. George Malcolm White, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 801 N Orange Ave, Suite 600, Orlando, FL 32801 Phone: 407-841-2100 Fax: 407-841-5705 | |
Dr. Christopher Thomas Aquina, MD, MPH Surgery Medicare: Medicare Enrolled Practice Location: 2415 N Orange Ave Ste 300, Orlando, FL 32804 Phone: 407-303-2615 | |
Dr. Elizabeth Patricia Bugarin, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 601 E Rollins St, Orlando, FL 32803 Phone: 407-303-7283 Fax: 407-303-0347 | |
Leanne M Iorio, DO Surgery Medicare: Medicare Enrolled Practice Location: 110 W Underwood St Ste A, Orlando, FL 32806 Phone: 407-422-3790 | |
Brittany N Warren, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 77 W Underwood St, Ste 300, Orlando, FL 32806 Phone: 407-649-6884 Fax: 407-245-7059 | |
Heather Walton, PA-C Surgery Medicare: Medicare Enrolled Practice Location: 4850 Millenia Blvd, Orlando, FL 32839 Phone: 407-264-5601 | |
Dr. Juan Sauer, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 9430 Turkey Lake Rd, Ste 114, Orlando, FL 32819 Phone: 407-354-1202 Fax: 407-351-8801 |